Actively Recruiting
A Study to Evaluate Single and Multiple Doses of SEP-479 in Healthy Adult Participants
Led by Septerna, Inc. · Updated on 2026-04-22
150
Participants Needed
1
Research Sites
47 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and food effects of oral SEP-479 in healthy adult participants.
CONDITIONS
Official Title
A Study to Evaluate Single and Multiple Doses of SEP-479 in Healthy Adult Participants
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Able and willing to provide informed consent
- Aged 21 to 60 years at the time of consent
- Body mass index (BMI) between 18.0 and 32.0 kg/m2
- Generally in good health
You will not qualify if you...
- Any condition that might risk participant's safety or compliance with the protocol
- Clinically significant abnormalities in laboratory results
- Recently or currently participating in other clinical trials
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Nucleus Network
Melbourne, Australia
Actively Recruiting
How is the study designed?
Study Type
INTERVENTIONAL
Masking
TRIPLE
Allocation
RANDOMIZED
Model
SEQUENTIAL
Primary Purpose
TREATMENT
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here